Apollomics (APLM) Cash & Equivalents (2020 - 2025)

Apollomics (APLM) has 5 years of Cash & Equivalents data on file, last reported at $3.3 million in Q4 2025.

• Cash & Equivalents for Q4 2025 came in at $3.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.3 million (changed N/A YoY), and the FY2025 annual result was $3.3 million, changed N/A from the prior year.
• Cash & Equivalents eased to $3.3 million in Q4 2025 per APLM's latest filing, from $25.3 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $32.7 million in Q4 2022 and troughed at $3.3 million in Q4 2025.
• A 4-year average of $16.9 million and a median of $15.9 million in 2021 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2021 and 2022: Cash & Equivalents slumped 95.04% in 2021, then soared 403.78% in 2022.
• A 4-year view of Cash & Equivalents shows it stood at $6.5 million in 2021, then soared by 403.78% to $32.7 million in 2022, then dropped by 22.58% to $25.3 million in 2023, then plunged by 87.05% to $3.3 million in 2025.
• Business Quant data shows APLM's Cash & Equivalents at $3.3 million in Q4 2025, $25.3 million in Q2 2023, and $32.7 million in Q4 2022.